MedPath

Assessment of the feasibility of a trial of individualised placement and support for people unemployed with chronic pai

Not Applicable
Completed
Conditions
Chronic pain and unemployment
Signs and Symptoms
Registration Number
ISRCTN30094062
Lead Sponsor
niversity of Southampton
Brief Summary

2020 Other publications in https://pubmed.ncbi.nlm.nih.gov/32280484/ stakeholder evaluation (added 09/12/2020) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32605914/ qualitative results (added 18/01/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33501902/ results (added 28/01/2021) 2022 Results article in https://doi.org/10.1017/s1463423622000342 (added 10/01/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
110
Inclusion Criteria

1. Participants who have taken part in the Individualised Placement Support scheme in Southampton or Portsmouth
2. Employment Support Workers who are currently working in the IPS scheme in Southampton and/or Portsmouth
3. Primary care staff will be invited to the focus group sessions if they are currently part of a team involved with patients with chronic pain in Southampton and/or Portsmouth
4. People with chronic pain who are unemployed for more than 3 months as a result of their health condition and who want to work

Exclusion Criteria

Individuals who are unable to speak English

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Feasibility of recruitment, assessed using qualitative focus group/semi-structured interviews in January-June 2017<br>2. The acceptability of randomisation, assessed by descriptive analysis of the pilot trial data (the proportion who agree to take part) in April 2017-September 2018<br>3. Drop outs from intervention/control arms, assessed by descriptive analysis of the pilot trial data (rates of attrition from each arm of the trial) in April 2017-September 2018<br>4. Drop outs over the follow-up period, assessed by descriptive analysis of the pilot trial data (rates of attrition during the trial) in April 2017-September 2018
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath